Referencer


  1. Stelfox HT, et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101-6.

  2. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-1170.

  3. Als-Nielsen B., et al. Association of Funding and Conclusions in Randomized Drug Trials. JAMA. 2003;290:921-928

  4. Orlowski JP and Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest. 1992; 102:270-273

  5. Wazana A. Physicians and the Pharmaceutical Industry: Is a gift ever just a gift? JAMA. 2000;283:373-80.

  6. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.

  7. Katz D, Caplan AL, Merz JF. All Gifts Large and Small. Am J Bioeth. 2003;3:39-46

  8. Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs-the importance of who says what. Family Practice 2003;20:61-68

  9. www.nofreelunch.org

  10. www.leger-mot-korrupsjon.net

  11. Spence D. PERSONAL VIEW: The danger of denial. BMJ 2004;329:631
 

Websiden er udviklet af  Mats Lindberg